Gen. Mgr., Precision Oncology
Mon, Feb 26, 2024
Feb 26
exercised or converted securities in EXAS
3,954 shares @ $0.00
Increased holdings by +40.50%
Option Exercise
Sale tied to a same-time option exercise
EXASEXACT SCIENCES CORP
Health CareHealth Care Services